Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations D Achelrod, U Wenzel, S Frey American journal of hypertension 28 (3), 355-361, 2015 | 233 | 2015 |
The economic burden of schizophrenia in Germany: a population-based retrospective cohort study using genetic matching S Frey European psychiatry 29 (8), 479-489, 2014 | 76 | 2014 |
Economic burden and quality-of-life effects of chronic lymphocytic leukemia: a systematic review of the literature S Frey, CR Blankart, T Stargardt Pharmacoeconomics 34, 479-498, 2016 | 36 | 2016 |
Cost–utility of internet-based cognitive behavioral therapy in unipolar depression: a markov model simulation M Baumann, T Stargardt, S Frey Applied health economics and health policy 18, 567-578, 2020 | 25 | 2020 |
Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data S Frey, Linder, Juckel European Journal of Health Economics, 2013 | 20* | 2013 |
The economic burden of cystic fibrosis in Germany from a payer perspective S Frey, T Stargardt, U Schneider, J Schreyögg Pharmacoeconomics 37, 1029-1039, 2019 | 14 | 2019 |
Performance of compliance and persistence measures in predicting clinical and economic outcomes using administrative data from German sickness funds S Frey, T Stargardt Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (10 …, 2012 | 8 | 2012 |
Durch Blutungen verursachte Kosten bei der Therapie des akuten Koronarsyndroms in Deutschland A Bufe, S Frey, S Briswalter Herz 34 (6), 479, 2009 | 6 | 2009 |
Do discontinuities in marginal reimbursement affect inpatient psychiatric care in Germany? C Pott, T Stargardt, U Schneider, S Frey The European Journal of Health Economics 22 (1), 101-114, 2021 | 2 | 2021 |
Costs caused by bleeds within the therapy of acute coronary syndromes in Germany A Bufe, S Frey, S Briswalter Herz Kardiovaskuläre Erkrankungen 34, 479-484, 2009 | 2 | 2009 |
Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework D Müller, A Gerber-Grote, B Stollenwerk, S Stock, PWP Auweiler, S Frey, ... Expert Review of Pharmacoeconomics & Outcomes Research 16 (5), 619-627, 2016 | 1 | 2016 |
PMH16 Analysis of the Economic Burden and Cost Structure of Schizophrenia in Germany Using Observational Sickness Fund Data S Frey, R Linder, T Stargardt Value in Health 15 (7), A336, 2012 | 1 | 2012 |
Does prospective payment influence quality of care? A systematic review of the literature C Pott, T Stargardt, S Frey Social Science & Medicine 323, 115812, 2023 | | 2023 |
Has Pharmaceutical Innovation Increased Persistence and Adherence of Multiple Sclerosis Patients in Germany? KE Fischer, S Frey, F Lichtenberg Value in Health 19 (7), A437, 2016 | | 2016 |
Economic Evaluation of Health Technologies Using Administrative Data S Frey | | 2014 |
AD1 Compliance Measurement Using Administrative Data From German Sickness Funds S Frey, T Stargardt Value in Health 14 (7), A233, 2011 | | 2011 |
PMH36 Cost-Effectiveness of Depot Flupentixol Versus Long-Acting Risperidone–A Markov Model Parameterized Using Administrative Data S Frey, T Stargardt, R Linder, G Juckel Value in Health 14 (7), A293, 2011 | | 2011 |
24th Annual Meeting of the German Drug Utilisation Research Group (GAA) S Frey, F Lichtenberg | | |